Local Elected Officials & Business Leaders Joined
Valeant Executives at South Carolina Plant
LAVAL, Quebec, Oct. 13, 2015 /PRNewswire/ -- Valeant
Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today
announced that the company celebrated the production of the four
billionth bottle of eye care products manufactured at Bausch +
Lomb's Greenville Solutions Plant, with Valeant Chairman and Chief
Executive Officer J. Michael Pearson
joining elected officials, employees, and local business leaders on
a tour of the South Carolina
facility. Commemorative bottles specially labeled to denote the
batch containing the four billionth bottle were produced for the
occasion.
The Bausch + Lomb solutions plant has been a staple of the
Greater Greenville community for
more than 30 years since opening in 1983. The plant employs a
workforce of more than 500 employees who help to manufacture more
than 30 essential medical products, which are then sent to a nearby
shipping facility to be packaged and transported around the world.
Among the top global Valeant brands manufactured at the
Greenville facility include
Biotrue® multi-purpose solution, ReNu®
Solutions, and Boston®
solutions for gas permeable contact lenses. Many of the Greenville
Solutions Plant's employees have worked at the site for more than
10 years.
Additionally, Valeant and Bausch + Lomb executives announced a
new, state-of-the-art, integrated line investment of approximately
$25 million. The expansion, coupled
with a previously approved solutions-making investment, will add 40
million units of capacity – an overall increase of more than 20
percent. More than 30 new jobs will be created from the increase in
capacity, with an expected $7 million
spent on local construction and engineering firms. Valeant is also
committing to new investments of approximately $90 million over the next two years, and
approximately $150 million over the
next five years, which is expected to result in 150 to 200 new jobs
in the next five years.
"Reaching this incredible milestone at Bausch + Lomb's
Greenville Solutions Plant demonstrates the enormous impact that
the facility has had across the globe," said Pearson.
"Whether it's one of the hundreds of employees creating our
top-of-the-line products, or a consumer who has bought one of our
four billion bottles manufactured at this facility for his or her
lens care needs, the work that is done here is essential to
peoples' lives. We are incredibly proud of the employees in
Greenville, who reflect the very
best of Valeant Pharmaceuticals."
"Congratulations to the Bausch + Lomb Greenville Solutions Plant
on your four billionth bottle, and to 32 years of bringing
manufacturing jobs to the Upstate," said Senator Lindsey Graham. "South Carolinians are
grateful to have such an essential business in our state, and we
look forward to many more years of success and positive community
impact."
"Longstanding businesses in our community have provided valuable
contributions to our thriving workforce," said Senator
Tim Scott. "Being able to
celebrate major production milestones underscores the dedication of
these businesses in our state, and reinforces South Carolina's role as the center of our
nation's manufacturing renaissance."
"Thank you to the Bausch + Lomb Greenville Solutions Plant for
the invitation to celebrate the production of its four billionth
bottle," said Representative Trey
Gowdy. "For over thirty years, the Greenville Bausch +
Lomb facility has continued to manufacture and export products
worldwide, supporting hundreds of jobs in the Upstate.
Congratulations on this achievement."
About Valeant Pharmaceuticals International, Inc.
Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a
multinational specialty pharmaceutical company that develops,
manufactures and markets a broad range of pharmaceutical products
primarily in the areas of dermatology, eye health, neurology and
branded generics. More information about Valeant Pharmaceuticals
International, Inc. can be found at www.valeant.com.
About Bausch + Lomb
Bausch + Lomb, a Valeant
Pharmaceuticals International, Inc. company, is a leading global
eye health organization that is solely focused on protecting,
enhancing, and restoring people's eyesight. Our core businesses
include ophthalmic pharmaceuticals, contact lenses, lens care
products, ophthalmic surgical devices and instruments. We
develop, manufacture and market one of the most comprehensive
product portfolios in our industry with products available in more
than 100 countries.
®/™ are trademarks of Bausch & Lomb
Incorporated or its affiliates.
© 2015 Bausch & Lomb
Incorporated.
News Media Contacts:
Laurie Little
SVP, Investor Relations
(949) 461-6002 or laurie.little@valeant.com
Kristy Marks
Manager, Product PR, Bausch + Lomb
(585) 338-8095 or kristy.marks@bausch.com
Mike Schrader
VP, Greenville Operations, Bausch + Lomb
(864) 281-2545 or michael.schrader@bausch.com
Logo -
http://photos.prnewswire.com/prnh/20101025/LA87217LOGO
Logo - http://photos.prnewswire.com/prnh/20151013/276471
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/valeant-pharmaceuticals-celebrates-the-manufacturing-of-four-billion-bottles-of-eye-care-products-at-bausch--lombs-greenville-solutions-plant-300158902.html
SOURCE Valeant Pharmaceuticals International, Inc.